Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol 2017;14:203–217

Article  PubMed  Google Scholar 

Ju MR, Yopp AC. Evolving thresholds for liver transplantation in hepatocellular carcinoma: a Western experience. Ann Gastroenterol Surg 2020;4:208–215

Article  PubMed  PubMed Central  Google Scholar 

Beal EW, Cloyd JM, Pawlik TM. Surgical treatment of intrahepatic cholangiocarcinoma: current and emerging principles. J Clin Med 2020;10:104

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Shi ZL, Yang X, et al. Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis. World J Gastroenterol 2014;20:142–147

Article  PubMed  PubMed Central  Google Scholar 

Janni W, Rack B, Kasprowicz N, et al. DTCs in breast cancer: clinical research and practice. Recent results in cancer research. Fortschritte der Krebsforschung Progres dans les recherches sur le Cancer 2012;195:173–178

CAS  PubMed  Google Scholar 

Wan JCM, Mughal TI, Razavi P, et al. Liquid biopsies for residual disease and recurrence. Med (New York, NY) 2021;2:1292–1313

CAS  Google Scholar 

Honoré N, Galot R, van Marcke C, et al. Liquid biopsy to detect minimal residual disease: methodology and impact. Cancers 2021;13:5364

Article  PubMed  PubMed Central  Google Scholar 

Siravegna G, Mussolin B, Venesio T, et al. How liquid biopsies can change clinical practice in oncology. Ann Oncol 2019;30:1580–1590

Article  CAS  PubMed  Google Scholar 

von Felden J, Garcia-Lezana T, Schulze K, et al. Liquid biopsy in the clinical management of hepatocellular carcinoma. Gut 2020;69:2025–2034

Article  Google Scholar 

Chen Z, Lin X, Chen C, et al. Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation. Ann Transl Med 2020;8:1067

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang PX, Xu Y, Sun YF, et al. Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation. Liver Int 2021;41:562–573

Article  CAS  PubMed  Google Scholar 

Huang A, Guo DZ, Wang YP, et al. Plasma MicroRNA panel predicts early tumor recurrence in patients with hepatocellular carcinoma after liver transplantation. J Cancer 2021;12:7190–7200

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou J, Sun H, Wang Z, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer 2020;9:682–720

Article  PubMed  PubMed Central  Google Scholar 

Li J, Jiang W, Wei J, et al. Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors. J Transl Med 2020;18:293

Article  CAS  PubMed  PubMed Central  Google Scholar 

Odegaard JI, Vincent JJ, Mortimer S, et al. Validation of a plasma-based comprehensive cancer genotyping assay utilizing orthogonal tissue- and plasma-based methodologies. Clin Cancer Res 2018;24:3539–3549

Article  CAS  PubMed  Google Scholar 

Koboldt DC, Zhang Q, Larson DE, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012;22:568–576

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 2019;16:589–604

Article  PubMed  PubMed Central  Google Scholar 

Halazun KJ, Najjar M, Abdelmessih RM, et al. Recurrence after liver transplantation for hepatocellular carcinoma: a new MORAL to the story. Ann Surg 2017;265:557–564

Article  PubMed  Google Scholar 

von Felden J, Villanueva A. Role of molecular biomarkers in liver transplantation for hepatocellular carcinoma. Liver Transpl 2020;26:823–831

Article  Google Scholar 

Akbulut S, Koc C. Do we need to be limited by matching milan criteria for survival in living donor liver transplantation? J Gastrointest Cancer 2020;51:1107–1113

Article  PubMed  Google Scholar 

Sarici B, Isik B, Yilmaz S. Management of recurrent HCC after liver transplantation. J Gastrointest Cancer 2020;51:1197–1199

Article  PubMed  Google Scholar 

Peng Y, Mei W, Ma K, et al. Circulating tumor DNA and minimal residual disease (MRD) in solid tumors: current horizons and future perspectives. Front Oncol 2021;11: 763790

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amado V, González-Rubio S, Zamora J, et al. Clearance of circulating tumor cells in patients with hepatocellular carcinoma undergoing surgical resection or liver transplantation. Cancers 2021;13:2476

Article  PubMed  PubMed Central  Google Scholar 

Huang A, Zhang X, Zhou SL, et al. Detecting circulating tumor dna in hepatocellular carcinoma patients using droplet digital PCR is feasible and reflects intratumoral heterogeneity. J Cancer 2016;7:1907–1914

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Huang A, Wang YP, et al. Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma. Ann Transl Med 2020;8:237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang A, Zhao X, Yang XR, et al. Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma. J Hepatol 2017;67:293–301

Article  CAS  PubMed  Google Scholar 

Ao H, Xin Z, Jian Z. Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma. Biomark Res 2021;9:91

Article  PubMed  PubMed Central  Google Scholar 

Deng Y, Sun L, Liang H, et al. Measurement of circulating tumor cells to track hepatocellular carcinoma progression after liver transplantation-case report. Front Oncol 2021;11: 760765

Article  PubMed  PubMed Central  Google Scholar